A new case–control study shows that inflammation on biopsy is associated with diagnosis of prostate cancer. We think a large population-based prospective study, specifically designed to investigate the longitudinal association between inflammation and subsequent onset of prostate cancer, is required to elucidate the true relationship between inflammation and prostate carcinogenesis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Platelet-to-lymphocyte ratio is not a predictor of clinically significant prostate cancer at the prostate biopsy: A large cohort study
Scientific Reports Open Access 09 July 2021
-
Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis
Cancer Cell International Open Access 25 March 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bostwick, D. G. et al. Human prostate cancer risk factors. Cancer 101 (Suppl.), 2371–2490 (2004).
De Marzo, A. M. et al. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 7, 256–269 (2007).
Corona, G. et al. Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. Int. J. Endocrinol. 2014, 329456 (2014).
Vignozzi, L. et al. Benign prostatic hyperplasia: a new metabolic disease? J. Endocrinol. Invest. 37, 313–322 (2014).
Gurel, B. et al. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol. Biomarkers Prev. 23, 847–856 (2014).
Irani, J. et al. High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy. Pathologist Multi Center Study Group. Urology 54, 467–472 (1999).
Davidsson, S. et al. Inflammation, focal atrophic lesions, and prostatic intraepithelial neoplasia with respect to risk of lethal prostate cancer. Cancer Epidemiol. Biomarkers Prev. 20, 2280–2287 (2011).
Yli-Hemminki, T. H. et al. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial. BJU Int. 112, 735–741 (2013).
Moreira, D. M. et al. Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study. Cancer 120, 190–196 (2014).
Grimes, D. A. & Schulz, K. F. False alarms and pseudo-epidemics: the limitations of observational epidemiology. Obstet. Gynecol. 120, 920–927 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Vignozzi, L., Maggi, M. Intriguing data on inflammation and prostate cancer. Nat Rev Urol 11, 369–370 (2014). https://doi.org/10.1038/nrurol.2014.143
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2014.143
This article is cited by
-
Platelet-to-lymphocyte ratio is not a predictor of clinically significant prostate cancer at the prostate biopsy: A large cohort study
Scientific Reports (2021)
-
Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis
Cancer Cell International (2019)
-
Meta-analysis of metabolic syndrome and prostate cancer
Prostate Cancer and Prostatic Diseases (2017)
-
Inflammatory mediators in the development and progression of benign prostatic hyperplasia
Nature Reviews Urology (2016)
-
Inflammation and prostate cancer: friends or foe?
Inflammation Research (2015)
